[HTML][HTML] 直接口服抗凝剂在老年非瓣膜性房颤抗凝治疗有效性与安全性方面的最新进展
钟少正， 袁忠明 - Advances in Clinical Medicine, 2022 - hanspub.org
… and making individualized anticoagulation treatment plan are the focus of clinical work. …
that direct oral anticoagulants were superior to warfarin in terms of effectiveness and safety. By …
that direct oral anticoagulants were superior to warfarin in terms of effectiveness and safety. By …
非维生素K 拮抗剂口服抗凝药治疗房颤的新进展
杨洁， 王晓明 - 心脏杂志, 2019 - heartj.cn
… Warfarin, as a traditional oral anticoagulant, has been recognized for its efficacy and safety.
… , frequent monitoring and other deficiencies of Warfarin have limited its clinical application …
… , frequent monitoring and other deficiencies of Warfarin have limited its clinical application …
直接口服抗凝血劑於腦靜脈栓塞治療的應用
YH Liao, YF Cheng, KC Chang, HY Chen - 臺灣臨床藥學雜誌, 2023 - airitilibrary.com
… 建議,CVT在急性期後以口服抗凝血劑warfarin做為栓塞復發的次級預防.由於直接口服抗凝血劑
(direct oral anticoagulant, DOAC)相較於warfarin,具有不須頻繁監測凝血功能與劑量調整的優勢,…
(direct oral anticoagulant, DOAC)相較於warfarin,具有不須頻繁監測凝血功能與劑量調整的優勢,…
左心耳封堵术与口服抗凝药物应用于心房颤动患者有效性及安全性的meta 分析
任艳霞， 安智晶， 张得梅， 郭雪娅 - 上海交通大学学报(医学版), 2021 - xuebao.shsmu.edu.cn
… treated with LAAC, compared with oral anticoagulant therapy (… treated with LAAC, compared
with oral anticoagulant therapy … appendage closure versus direct oral anticoagulants in high-…
with oral anticoagulant therapy … appendage closure versus direct oral anticoagulants in high-…
[HTML][HTML] 非瓣膜性心房颤动口服抗凝药物临床应用研究进展
朱虹， 赵德斌， 施蕾， 李红 - Advances in Clinical Medicine, 2024 - hanspub.org
… (oral anticoagulant therapy, OAT)是NVAF高危患者缺血性卒中预防的基石.目前,指南推荐将直接
口服抗凝药(direct oral anticoagulants, … 然而,口服抗凝药(oral anticoagulant, OAC)的应用存在…
口服抗凝药(direct oral anticoagulants, … 然而,口服抗凝药(oral anticoagulant, OAC)的应用存在…
[PDF][PDF] 直接口服抗凝药与华法林在有大出血史房颤患者中有效性和安全性的meta 分析
周强， 魏萌， 黄晓晖， 吴燕子， 杨元素， 陶瑛瑛 - 临床药物治疗杂志, 2022 - lcywzlzz.com
… [Abstract] Objective To evaluate the efficacy and safety of direct oral anticoagulants and
warfarin in the treatment of pa⁃ tients with atrial fibrillation with a history of major bleeding,and …
warfarin in the treatment of pa⁃ tients with atrial fibrillation with a history of major bleeding,and …
直接口服抗凝剂: 一种针对阿尔茨海默病的新疗法?
K Grossmann - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
… how they can be treated with direct oral anticoagulants (DOACs). Anticoagulants are drugs
that are used … A medication based on anticoagulants for treatment of neurodegenerative brain …
that are used … A medication based on anticoagulants for treatment of neurodegenerative brain …
[PDF][PDF] 新型口服抗凝药治疗不同体质指数房颤患者的有效性和安全性的Meta 分析
李宇， 冯晓俊， 樊晖晖， 张蕾， 陈琴， 王运红… - 临床药物治疗 …, 2020 - lcywzlzz.com
… Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and low body weight[J]…
Comparative effec⁃ tiveness,safety,and costs of rivaroxaban and warfarin among morbidly …
Comparative effec⁃ tiveness,safety,and costs of rivaroxaban and warfarin among morbidly …
在癌症和非癌症患者中非维生素K 拮抗剂口服抗凝药的相对效益分析: 随机对照试验的Meta 分析
王晨曦， 杨萍萍， 李忠城， 邬涛， 吴清华 - 临床心血管病杂志, 2020 - lcxxg.whuhzzs.com
… Comerota AJ,Ramaccioyyi EA comprehensive overview of direct oral anticoagulants for
the management of venous thromboembolism[J].Am J Med Sci,2016,352(1):92-106. …
the management of venous thromboembolism[J].Am J Med Sci,2016,352(1):92-106. …
非維他命K 拮抗劑口服抗凝血劑與抗癲癇藥物交互作用之探討
陳柏安， 林雅如， 傅維仁 - 台灣中風醫誌, 2020 - airitilibrary.com
… oral anticoagulant[NOAC])已被廣泛 使用在非瓣膜性心房顫動病人缺血性中風的初級或次級預防
.相較於傳統抗凝血劑warfarin,… interest between direct oral anticoagulants and antiepileptic …
.相較於傳統抗凝血劑warfarin,… interest between direct oral anticoagulants and antiepileptic …